COPD-X https://validator.w3.org/feed/docs/rss2.html O10. Palliative and supportive care O4.4 Biologic therapies COPD-X Plan Guidelines X3.2 Non-invasive ventilation References S-Z References H-R References A-G C2. Diagnosis C3. Assessing the severity of COPD Home C2.6 Incidental findings (National Lung Cancer Screening Program) P10. Oxygen therapy P: Prevent deterioration Appendix List of Boxes X3.9 Clinical review and follow-up X3.7 Discharge planning X: Manage eXacerbations P5. Long-acting bronchodilators D3. Self-management X3. Refer appropriately to prevent further deterioration (‘P’) Register for PDF Levels of evidence Introduction O1.2.2 Long-acting beta2-agonists (LABA) O7.2.2 Safety of beta-blockers List of Figures D5. Assessment and management of anxiety and depression D1.9 Pharmacist D: Develop a plan of care P7. Mucolytic agents P2.4 Respiratory syncytial virus immunisation O7.2 Cardiac disease O6.1 Pulmonary rehabilitation C2.3 Spirometry C: Case finding and confirm diagnosis C6. Specialist referral C5. Further investigations Clinical Summary Tools O5. Inhaler use C1. Aetiology and natural history O1.2.3 Long-acting bronchodilator combinations (LAMA/LABA) O1.2 Long-acting bronchodilators D6. Referral to a support group P1. Risk factor reduction O6.2 Exercise training X2. COPD exacerbation management O6.5 Physical activity and sedentary behaviour D1.1 General Practitioner X2.2 Optimise treatment